Neonatal arterial thrombosis associated with maternal paraganglioma: a case report
Main Article Content
Abstract
Introduction: Neonatal arterial thrombosis is a rare but life-threatening condition, most often associated with umbilical catheterization, congenital thrombophilia, or perinatal complications. Maternal pheochromocytomas and paragangliomas (PPGLs) are rare during pregnancy, and their impact on neonatal hemostasis remains poorly understood. Objective: To describe a case of neonatal arterial thrombosis associated with maternal PPGL and its implications for neonatal care. Case description: We report a case of neonatal arterial thrombosis associated with maternal paraganglioma. A female neonate was born at 37 weeks via cesarean section to a 29-year-old woman with a 9.4 cm retroperitoneal paraganglioma. The infant had normal Apgar scores (9/9) and birth weight of 2,922g. On admission to the neonatal intensive care unit, she exhibited pallor, cyanosis, and decreased temperature of the left lower limb. Doppler ultrasound revealed a thrombus extending from the common femoral artery to the superficial femoral artery origin. Thrombophilia screening was negative. The mother experienced severe postpartum hypertension requiring nitroprusside, suggesting massive catecholamine release during delivery. The infant was treated with intravenous heparin followed by subcutaneous enoxaparin. Follow-up Doppler ultrasound at 20 days showed complete thrombus resolution and the infant was discharged without complications. Discussion: Excessive maternal catecholamine release during delivery may overwhelm placental metabolic capacity, leading to fetal exposure and subsequent arterial thrombosis. Pediatric healthcare providers should be aware of this potential risk, as early recognition and prompt anticoagulation therapy can lead to favorable outcomes.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Khizroeva J, Makatsariya A, Vorobev A, Bitsadze V, Elalamy I, Lazarchuk A, et al. The hemostatic system in newborns and the risk of neonatal thrombosis. Int J Mol Sci. 2023;24(18):13864. doi:10.3390/ijms241813864.
2. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv. 1999;54(11):728.
3. Bacciedoni V, Attie M, Donato H; Comité Nacional de Hematología, Oncología y Medicina Transfusional. Thrombosis in newborn infants. Arch Argent Pediatr. 2016;114(2):159-166. doi:10.5546/aap.2016.eng.159.
4. Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942.
5. Davenport P, Sola-Visner M. Hemostatic challenges in neonates. Front Pediatr. 2021;9:627715. doi:10.3389/fped.2021.627715.
6. Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665-675.
7. Farrugia FA, Charalampopoulos A. Pheochromocytoma. Endocr Regul. 2019;53(3):191-212. doi:10.2478/enr-2019-0020.
8. Prejbisz A, Lenders JWM, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011;29(11):2049-2060.
9. Seely EW, Ecker J. Chronic hypertension in pregnancy. N Engl J Med. 2011;365(5):439-446.
10. Cameron NA, Blyler CA, Bello NA. Oral contraceptive pills and hypertension: a review of current evidence and recommendations. Hypertension. 2023;80(5):924-935.
11. Langton K, Tufton N, Akker SA, Deinum J, Eisenhofer G, Timmers HJLM, et al. Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome – a systematic review. BJOG. 2021;128(8):1264-1272.
12. Kushner A, West WP, Khan SMZ. Virchow triad. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.
13. Lenders JWM, Langton K, Langenhuijsen JF, Eisenhofer G. Pheochromocytoma and pregnancy. Endocrinol Metab Clin North Am. 2019;48(3):605-617.
14. Clifton-Bligh RJ. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy. Rev Endocr Metab Disord. 2023;24(1):49-56.
15. Bancos I, Atkinson E, Eng C, Young WF Jr, Neumann HPH. Maternal and fetal outcomes in pheochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. Lancet Diabetes Endocrinol. 2021;9(1):13-21.